Status:
UNKNOWN
Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients
Lead Sponsor:
Sohag University
Conditions:
COVID-19
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Patients infected with covid-19 have a series of clinical manifestations, including fever, cough, myalgia or fatigue, dyspnea, even acute respiratory distress syndrome (ARDS), acute cardiac injury and...
Eligibility Criteria
Inclusion
- COVID 19 hospitalized patients (diagnosed by RT-PCR)
Exclusion
- Age below 18 years and above 80.
Key Trial Info
Start Date :
December 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05201625
Start Date
December 15 2021
End Date
December 1 2022
Last Update
January 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University Hospital
Sohag, Egypt